GSA CAPITAL PARTNERS LLP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$401
-43.6%
25,446
-30.4%
0.03%
-52.1%
Q2 2023$711
+76.0%
36,582
+157.2%
0.07%
+77.5%
Q1 2023$404
-99.9%
14,224
-38.5%
0.04%
-50.6%
Q3 2022$611,000
-19.4%
23,137
+35.7%
0.08%
-28.9%
Q2 2022$758,000
-6.8%
17,056
+3.9%
0.11%
+4.6%
Q1 2022$813,000
+234.6%
16,420
+244.7%
0.11%
+251.6%
Q4 2021$243,000
-14.1%
4,763
-22.5%
0.03%
-56.3%
Q1 2020$283,000
-54.6%
6,142
-40.8%
0.07%
-2.7%
Q4 2019$623,000
-7.0%
10,367
-12.5%
0.07%
-19.8%
Q3 2019$670,000
-36.7%
11,842
-37.7%
0.09%
-22.9%
Q2 2019$1,058,000
-9.1%
19,006
-17.6%
0.12%0.0%
Q1 2019$1,164,000
-10.8%
23,052
-28.9%
0.12%
-21.9%
Q4 2018$1,305,000
-21.2%
32,400
+35.6%
0.15%
+64.1%
Q3 2018$1,657,000
+313.2%
23,900
+350.9%
0.09%
+360.0%
Q2 2018$401,000
-2.4%
5,300
-32.1%
0.02%
-9.1%
Q1 2018$411,000
-80.7%
7,800
-80.4%
0.02%
-82.9%
Q4 2017$2,126,000
+124.3%
39,800
+150.3%
0.13%
+98.5%
Q3 2017$948,000
-57.8%
15,900
-44.2%
0.06%
-55.8%
Q2 2017$2,248,000
-15.3%
28,500
-10.9%
0.15%
+3.5%
Q1 2017$2,654,000
+102.9%
32,000
-0.9%
0.14%
+71.1%
Q1 2016$1,308,000
+90.1%
32,296
+316.3%
0.08%
+144.1%
Q4 2015$688,000
-8.4%
7,757
-23.5%
0.03%
-8.1%
Q3 2015$751,000
-16.6%
10,145
-52.8%
0.04%
+2.8%
Q1 2015$901,00021,5000.04%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders